EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 528.66B
Enterprise Value 328.21B
Trailing P/E 52.33
Forward P/E 126.35
PEG Ratio (5 yr expected) 12.37
Price/Sales (ttm)8.31
Price/Book (mrq)8.83
Enterprise Value/Revenue 38.19
Enterprise Value/EBITDA 626.72

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 16.25%
Operating Margin (ttm)28.32%

Management Effectiveness

Return on Assets (ttm)11.51%
Return on Equity (ttm)18.70%

Income Statement

Revenue (ttm)3.45B
Revenue Per Share (ttm)16.36
Quarterly Revenue Growth (yoy)1.30%
Gross Profit (ttm)2.56B
EBITDA 1.06B
Net Income Avi to Common (ttm)560M
Diluted EPS (ttm)2.60
Quarterly Earnings Growth (yoy)-10.30%

Balance Sheet

Total Cash (mrq)1.5B
Total Cash Per Share (mrq)7.11
Total Debt (mrq)1.05B
Total Debt/Equity (mrq)32.49
Current Ratio (mrq)2.07
Book Value Per Share (mrq)15.40

Cash Flow Statement

Operating Cash Flow (ttm)1.02B
Levered Free Cash Flow (ttm)552.36M

Trading Information

Stock Price History

Beta 0.70
52-Week Change 320.04%
S&P500 52-Week Change 313.05%
52 Week High 3143.22
52 Week Low 3100.20
50-Day Moving Average 3135.84
200-Day Moving Average 3127.13

Share Statistics

Avg Vol (3 month) 31.38M
Avg Vol (10 day) 31.02M
Shares Outstanding 5210.78M
Float 209.26M
% Held by Insiders 13.94%
% Held by Institutions 10.00%
Shares Short 32.23M
Short Ratio 31.23
Short % of Float 31.06%
Shares Short (prior month) 32.8M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 22/1
Last Split Date 3Dec 14, 2015